Past events



Female Founder exclusives, discounts and more.


20 July 13:30-15:00
Virtual Roundtable Members only

Member Meet-Up and Ask the Investors Roundtable

A chance for members to get face time with top investors in life sciences and healthtech in a relaxed setting. The session explores what investors are specifically looking for in their founders, how to pitch well and demonstrate credibility, common pitfalls first-time founders experience and “must know” advice. The first 30 minutes are dedicated to our first members meet-up.

Jonathan Synett, Chief Investment Officer, NCL Technology Ventures
Anoop Maini, CEO, Excite Ventures
Fiona MacLaughlin, Senior Director, Johnson & Johnson Innovation, JJDC
Inga Deakin, Principle, DraperEsprit
Moderator: Angela Tyrell, SVP, LSX & Female Founders

Jonathan Synett, Chief Investment Officer, NCL Technology Ventures    Anoop Maini, CEO, Excite Ventures    Fiona MacLaughlin, Senior Director, Johnson & Johnson Innovation, JJDC    Inga Deakin, Principle, DraperEsprit    Angela Tyrell, SVP, LSX & Female Founders


Thursday 13th May 
Women’s health investment priorities including “taboo tech” growth markets, inclusivity and equality

Women’s health is gaining ground as an important market segment. But it still desperately needs more investment. This session looks at why women’s health is so lucrative and how it extends beyond Femtech to complex medical solutions. It also looks at how to stimulate investment in female founders and putting women’s health at the top of more VC agendas.

Marie Laure Mahe, Vice President Business Development, Europe, Essity Ventures
Lucanus Polagnoli, Co-Founder, Calm/Storm Ventures
Deepali Nangia, Co-Founder, Alma Angels
Maria Velissaris, Founding Partner, SteelSky Ventures

Marie Laure Mahe, Vice President Business Development, Europe, Essity Ventures    Lucanus Polagnoli, Co-Founder, Calm/Storm Ventures    Deepali Nangia, Co-Founder, Alma Angels    Maria Velissaris, Founding Partner, SteelSky Ventures

 


Thursday 13th May
“Women’s health is global health” – seizing market opportunities in period care, incontinence and sexual wellbeing

Some of the world’s most interesting SMEs tackling an array of women’s health concerns including period care, incontinence and sexual wellbeing look at how to launch a successful women’s health brand including busting taboos, fund raising, product manufacturing, distribution and marketing.

Gloria Kolb, Co-Founder and CEO, Elidah
Frances Tang, Founder, Awkward Essentials
Daniella Peri, CEO, Yoppie
Arion Long, Founder and CEO, Femly

Gloria Kolb, Co-Founder and CEO, Elidah    Frances Tang, Founder, Awkward Essentials    Daniella Peri, CEO, Yoppie    Arion Long, Founder and CEO, Femly

 


Friday 30th April 
Building a diverse leadership team and board

In the recently released Deerfield Report an analysis of 140 venture-backed health and life science companies found that nearly half had no female board members. And, of the six who managed to achieve 50% women on their board, all but one had a female CEO. For all the talk about the importance of diversity at the most senior levels, in reality there are still too many very real barriers to achieving it. This webinar addresses the problem head-on, including some tangible changes that might be implemented to build a diverse leadership team and board, including:

  • What are the risks of hiring based on competency over experience? What are the potential benefits? How to navigate board and investor objections.
  • Weighing up the relative benefits of tangible solutions like rewriting policies, interview targets or quotas and unconscious bias training, by looking at them through an “idealist vs realist” lens
  • How will the demand for diverse boards and leadership teams evolve in the next five years? What is the commercial risk of not taking gender parity seriously? What is the outcome if they fail to adapt?

Priya Mande, COO, PsiOxus Therapeutics
Keren Leshem, CEO, OCON Healthcare
Sabine Dandiguian, Managing Partner, Jeito Life
Houman Ashrafian
, Managing Partner, SV Health Investors
Moderator: Malcolm Silander, Co-Founder, Precision Biosearch

Priya Mande, COO, PsiOxus Therapeutics    Keren Leshem, CEO, OCON Healthcare    Sabine Dandiguian, Managing Partner, Jeito Life    Houman Ashrafian, Managing Partner, SV Health Investors    Malcolm Silander, Co-Founder, Precision Biosearch

 


Tuesday 30th March
Ask the Investors Roundtable

A chance for members to get face time with top investors in life sciences and healthtech in a relaxed setting. The session explores what investors are specifically looking for in their founders, how to pitch well and demonstrate credibility, common pitfalls first-time founders experience and “must know” advice.

Diana Saraceni, Partner, Panakes Partners
Leigh Brody, Investment Manager, AlbionVC
Eva Tarasova, Investment Director, Wharton Asset Management
Alexandra Bause, Investment Director, Apollo Health Venture
Inga Deakin, Principal, Draper Esprit

Diana Saraceni, Partner, Panakes Partners    Leigh Brody, Investment Manager, AlbionVC    Eva Tarasova, Investment Director, Wharton Asset Management    Alexandra Bause, Investment Director, Apollo Health Venture    Inga Deakin, Principal, Draper Esprit

 


Thursday 4th February 2020 (Part of the LSX World Congress)
Female Founders – Encouraging, Developing and Commercialising Talent


Inspiring female founders discuss the challenges they have faced in building their life science and healthcare businesses, raising capital in a male-dominated industry, and what more can and should be done to expedite growth and equality in female entrepreneurship and leadership in life sciences.

Sharon Cunningham, Co-Founder & CEO, Shorla Pharma
Lea Von Bidder, Co-Founder & CEO, Ava
Caroline Barelle, Co-Founder & CEO, Elasmogen
Valerie Vanhooren, CEO, ONA Therapeutics
Fiona MacLaughlin, Senior Director, Johnson & Johnson Innovation
Moderator: Angela Tyrell, SVP, LSX & Female Founders

Sharon Cunningham, Co-Founder & CEO, Shorla Pharma    Lea Von Bidder, Co-Founder & CEO, Ava    Caroline Barelle, Co-Founder & CEO, Elasmogen    Valerie Vanhooren, CEO, ONA Therapeutics    Fiona MacLaughlin, Senior Director, Johnson & Johnson Innovation    Angela Tyrell, SVP, LSX & Female Founders

 



DOWNLOAD BROCHURE